Eli Lilly Swings To 3Q Profit Amid Year-Ago Zyprexa Charge (Pink Sheet)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Pfizer earnings up 26% despite lower sales of many drugs (Pharma Times)
Biogen profits leap as Tysabri sales soar again (Pharma Times)
Sanofi-Aventis and Wellstat Therapeutics Enter into an Exclusive Worldwide
Licensing Agreement for Novel Oral Agent to Treat Type II Diabetes (Pharma Live)
Earnings Preview: Bristol-Myers 3Q earnings report (Forbes.com)
AstraZeneca PLC – SWOT Analysis company profile is the essential
source for top-level company data and information. (PR Minds)
FDA Denies P&G Petition For OTC Proton Pump Inhibitor Class Labeling (Health News Daily)
This is copyright protected information, to receive the full article, please click here to sign up and register.
Watch for Amgen Inc. earnings Wednesday; AMGN, GILD, CELG (LearningMarkets.com)
Health-care lobbyists continue spending spree (Washington Post)
SUBSCRIBE